ClinVar Miner

Submissions for variant NM_001042492.3(NF1):c.4760del (p.Ala1586_Leu1587insTer)

dbSNP: rs2151470108
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001884129 SCV002151283 pathogenic Neurofibromatosis, type 1 2021-10-04 criteria provided, single submitter clinical testing This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with NF1-related conditions. For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Leu1566*) in the NF1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NF1 are known to be pathogenic (PMID: 10712197, 23913538).
Fulgent Genetics, Fulgent Genetics RCV002478255 SCV002788487 likely pathogenic Neurofibromatosis, familial spinal; Juvenile myelomonocytic leukemia; Neurofibromatosis, type 1; Neurofibromatosis-Noonan syndrome; Café-au-lait macules with pulmonary stenosis 2021-08-09 criteria provided, single submitter clinical testing
Mayo Clinic Laboratories, Mayo Clinic RCV004793570 SCV005413206 likely pathogenic not provided 2023-10-06 criteria provided, single submitter clinical testing PM2_moderate, PVS1

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.